Mitochondrial dysfunction is a central driver of cellular senescence, a core hallmark of aging. While intrinsic mechanisms have been extensively reviewed, this article offers a novel paradigm by emphasizing the critical role of interorganellar communication in mitochondria-mediated senescence. We present a systematic dissection of the molecular mechanisms underlying functional crosstalk between mitochondria and key organelles, including the endoplasmic reticulum (ER), lysosomes, and peroxisomes. A particular focus is placed on established regulatory hubs such as mitochondria-associated ER membranes (MAMs), which orchestrate calcium signaling, lipid metabolism, and inflammatory responses. We further explore emerging pathways involving lysosomal mitochondrial coordination in nutrient sensing and mitophagy, and peroxisomal mitochondrial cooperation in redox balance and lipid homeostasis. By elucidating how defects in these dynamic networks propagate mitochondrial damage and execute senescence, this review establishes a unified framework for aging as integrated organelle network dysfunction. This synthesis advances fundamental aging biology and identifies novel molecular targets, providing a foundation for developing therapeutic strategies targeting organelle networks against age related pathologies.
Diet is a key regulatory factor for the gut microbiota, profoundly influencing its composition and metabolic activities, and is of great significance to the occurrence and development of atherosclerosis. Dysregulation of the gut microbiota can alter the production of key microbial metabolites. These metabolites play a crucial role in regulating host lipid metabolism, inflammatory responses, and endothelial integrity, and these factors are closely related to the pathogenesis of atherosclerotic plaques. In this review, we identify several key findings. Short-chain fatty acids, particularly butyrate and propionate, exert anti-atherosclerotic effects by promoting regulatory T cell differentiation, inhibiting histone deacetylases, and improving endothelial function. Bile acids modulate atherosclerosis via farnesoid X receptor and TGR5 signaling, with microbiota-mediated secondary bile acid composition playing a critical but species-dependent role. Tryptophan metabolites derived from both host and microbial metabolism exhibit dual roles in vascular inflammation, with indole-3-propionic acid and indole-3-carboxaldehyde showing consistent atheroprotective effects in preclinical models. Trimethylamine N-oxide is consistently associated with increased cardiovascular risk in observational studies, yet causal evidence in humans remains inconclusive. A high-fiber and plant-based diet can promote the growth of beneficial microbiota and the production of short-chain fatty acids, while a Western and high-protein diet can increase proteolytic bacteria and raise the level of trimethylamine N-oxide. In addition, food and medicine homologous compounds (including saponins, flavonoids, polysaccharides, and alkaloids) can regulate the composition of the gut microbiota and the activity of microbial enzymes, which represents a promising but unvalidated therapeutic strategy. This review consolidates the evidence regarding the intricate interplay between dietary habits, gut microbiota, and metabolite dynamics, highlighting their collective influence on atherosclerotic cardiovascular disease.
1 January 2025 in Computational and Structural Biotechnology Journal
Recent advances in epigenetics have elucidated the pivotal roles of epigenetic modifications in genomic regulation and disease pathogenesis. Concurrently, CRISPR-based technologies have transcended conventional gene-editing applications and have emerged as powerful tools for target gene screening, chromatin imaging, and epigenetic modulation. Notably, epigenetic landscapes substantially influence the CRISPR editing efficiency, whereas CRISPR itself can reshape epigenetic states, forming a dynamic CRISPR-Epigenetics Regulatory Circuit. This review systematically examines the bidirectional interplay between CRISPR systems and epigenetic modifications, emphasizing their collective impact on genome-editing precision, disease progression, and therapeutic development. Existing studies have predominantly focused on the application of CRISPR in epigenetic modifications or the impact of epigenetic landscapes on CRISPR, exhibiting unidirectional characteristics. However, accumulating evidence suggests a bidirectional interaction between the two. Here, a transformative "CRISPR-Epigenetics Regulatory Circuit" model is synthesized and presented, supported by three pivotal breakthroughs: demonstrating CRISPR as an active epigenetic programmer, synthesizing the epigenetic preconditioning therapeutic paradigm, and elucidating the first predictive mathematical model (EPIGuide). Further exploration of this circuit is expected to enhance CRISPR performance, optimize sgRNA design via epigenetic predictive models, and pioneer sequential epigenetic or gene editing therapies.